CTRI/2023/07/055921尚未招募Unknown
tility of (1â??3)-β-D Glucan (BDG) in the management of invasive fungal diseases in critical care unit - NI
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Above 18 years of age who are admitted in critical acre unit for whom BDG test ahs been ordered
排除标准
- •No specific exclusion criteria
研究者
相似试验
已完成
不适用
Evaluation of (1->3)-Beta-D-Glucan as a Diagnostic Tool for HIV associated Pneumocystis PneumoniaJPRN-UMIN000014818ational Center for Global Health and Medicine180
尚未招募
Unknown
diagnosis of invasive fungal infectionsCTRI/2023/07/055119Max Super Speciality Hospital
招募中
不适用
(1-3)-beta-D-glucan ans mannan guided early termination of antifungal therapy in ICU patientsB37.7R65.0R65.1B37.9Candidal sepsisSystemic Inflammatory Response Syndrome of infectious origin without organ failureSystemic Inflammatory Response Syndrome of infectious origin with organ failureCandidiasis, unspecifiedDRKS00016700niklinik ErlangenMikrobiologisches Institut160
Unknown
2 期
Development The Potentiality of β-1,3/1,6-D-Glucan (Polysaccharide Peptide) From Mycelia Extract of Indonesia's Ganoderma Lucidum as Adjuvant Therapy in Patients With Cardiometabolic SyndromeCardiometabolic SyndromeNCT05079529University of Brawijaya70
已完成
Unknown
(1,3)-ß-D-glucan based diagnosis of invasive candida infection versus culture based diagnosis in patients with severe sepsis or septic shock and a high risk for invasive candida infection.Severe sepsis, septic shockA41Other sepsisDRKS00010285Friedrich-Schiller-Universität JenaMedizinische Fakultät342